Searchable abstracts of presentations at key conferences in endocrinology

ea0011oc23 | Clinical endocrinology | ECE2006

Improved Prognosis in Midgut Carcinoid patients by treating raised circulating Neurokinin A (NKA)

Ardill JES , Johnston BJ , Turner GB , McGinty A , McCance DR

Midgut Carcinoid disease (MGC) is uncommon, occurring in approximately 1.4 per 100,000 of the population per year. MGC has an unpredictable disease progression varying from rapid and aggressive to slow and indolent. For this reason it is not appropriate to treat all patients according to the same schedule. As some treatments are not without risk, it is important to identify those patients selected for these options at an appropriate stage of disease.In a...

ea0044p28 | Adrenal and Steroids | SFEBES2016

Incidence and outcomes of hormone-secreting adrenal tumours in pregnancy: a UK 4 year prospective cohort study

Quartermaine Georgia , Lambert Kimberley , Rees Kate , Seed Paul , Dhanjal Mandish , Knight Marian , McCance DR , Williamson Catherine

Objective: To examine the monitoring, management and outcomes of adrenal tumours in pregnancy.Design: A national, prospective observational, cohort study over 4 years using the UK Obstetric Surveillance System (UKOSS).Setting: Consultant led obstetric units.Patients: Women with hormone-secreting adrenal tumours (pheochromocytoma, primary aldosteronism or Cushing’s syndrome) diagnosed before or during pre...

ea0019p349 | Thyroid | SFEBES2009

The outcome of treatment of relapsed hyperthyroidism with a fixed dose of 550 MBq radioiodine

Lewis AS , Rea T , Atkinson AB , Bell PM , Courtney CH , McCance DR , Mullan K , Hunter SJ

Radioiodine is the treatment of choice for relapsed hyperthyroidism although the optimum protocol is uncertain. We assessed the outcome of therapy with 131I in relapsed hyperthyroidism using a fixed dose regimen.We retrospectively studied 449 patients (M: F 82: 367; age range 13–89 y, median 42 y) treated between 2003 and 2007 with a fixed dose of 550 MBq 131I for relapsed hyperthyroidism. Patients were classified as either Gra...